● Recruiting
Phase I
Oncology
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
What is being tested: GDC-7035, a novel investigational agent, is undergoing first-in-human evaluation for safety, pharmacokinetics, and anti-cancer activity both as monotherapy and in…
04 May 2026
NCT06619587